Cleveland BioLabs, Inc. (NASDAQ: CBLI) stock was tossed up almost 30% to $3.7 in the late hours on Friday after the reports that in connection with the merger of CBLI with Cytocom, the Lifshitz Law Firm, P.C. is investigating possible breaches of fiduciary duties. CBLI investors who wish to learn more about our investigation should complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Read More
